Development of prognostic signatures for intermediate-risk papillary thyroid cancer

被引：0
|
作者：
Kevin Brennan
Christopher Holsinger
Chrysoula Dosiou
John B. Sunwoo
Haruko Akatsu
Robert Haile
Olivier Gevaert
机构：
[1] Stanford University,Division of Biomedical Informatics Research, Department of Medicine
[2] Stanford University,Division of Head and Neck Surgery, Department of Otolaryngology—Head and Neck Surgery
[3] Stanford University,Division of Endocrinology, Department of Medicine
[4] Stanford University,Division of Oncology, Department of Medicine
[5] Stanford University,Stanford Center for Biomedical Informatics Research, Department of Medicine & Department of Biomedical Data Science
来源：
BMC Cancer | / 16卷
关键词：
Papillary thyroid cancer; Prognosis; Gene expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Development of prognostic signatures for intermediate-risk papillary thyroid cancer
    Brennan, Kevin
    Holsinger, Christopher
    Dosiou, Chrysoula
    Sunwoo, John B.
    Akatsu, Haruko
    Haile, Robert
    Gevaert, Olivier
    [J]. BMC CANCER, 2016, 16
  • [2] Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
    Zhao, Hengqiang
    Gong, Yiping
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [3] Selective Use of Radioactive Iodine in Intermediate-Risk Papillary Thyroid Cancer
    Nixon, Iain J.
    Patel, Snehal G.
    Palmer, Frank L.
    DiLorenzo, Monica M.
    Tuttle, R. Michael
    Shaha, Ashok
    Shah, Jatin P.
    Ganly, Ian
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2012, 138 (12) : 1141 - 1146
  • [4] Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer-To Treat or Not to Treat
    van Velsen, Evert F. S.
    Verburg, Frederik A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (10): : E1149 - E1150
  • [5] The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer
    Wang, Xiaofei
    Zhu, Jingqiang
    Li, Zhihui
    Wei, Tao
    [J]. PLOS ONE, 2020, 15 (06):
  • [6] Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer
    Nixon, Iain J.
    Ganly, Ian
    [J]. FUTURE ONCOLOGY, 2013, 9 (07) : 921 - 923
  • [7] Risk factors for posttreatment recurrence in patients with intermediate-risk papillary thyroid carcinoma
    Kim, Yonghan
    Roh, Jong-Lyel
    Song, Dong Eun
    Cho, Kyung-Ja
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    [J]. AMERICAN JOURNAL OF SURGERY, 2020, 220 (03): : 642 - 647
  • [8] Response to Surgery Assessments for Sparing Radioiodine Remnant Ablation in Intermediate-Risk Papillary Thyroid Cancer
    Zhang, Xin
    Liu, Jie-Rui
    Mu, Zhuan-Zhuan
    Cheng, Xin-Qi
    Lin, Yan-Song
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (06): : 1330 - 1337
  • [9] Predictors of distant metastatic recurrence in intermediate-risk papillary thyroid carcinoma
    Onoda, Naoyoshi
    Ito, Yasuhiro
    Miya, Akihiro
    Kihara, Minoru
    Miyauchi, Akira
    [J]. WORLD JOURNAL OF SURGERY, 2024,
  • [10] Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy
    Enrique Llamas-Olier, Augusto
    Isabel Cuellar, Diana
    Buitrago, Giancarlo
    [J]. THYROID, 2018, 28 (10) : 1311 - 1317
12345